-
Preferences and ease of use of preservative-free IOP-lowering eye drop containers: A comparison of two multi-dose bottles
Kai Kaarniranta and Auli Ropo
Case Report: Clinical Investigation
-
Preferences and ease of use of preservative-free IOP-lowering eye drop containers: A comparison of two multi-dose bottles
Kai Kaarniranta and Auli Ropo
Case Report: Clinical Investigation
-
Preferences and ease of use of preservative-free IOP-lowering eye drop containers: A comparison of two multi-dose bottles
Kai Kaarniranta and Auli Ropo
Case Report: Clinical Investigation
-
Preferences and ease of use of preservative-free IOP-lowering eye drop containers: A comparison of two multi-dose bottles
Kai Kaarniranta and Auli Ropo
Case Report: Clinical Investigation
-
Preferences and ease of use of preservative-free IOP-lowering eye drop containers: A comparison of two multi-dose bottles
Kai Kaarniranta and Auli Ropo
Case Report: Clinical Investigation
-
Preferences and ease of use of preservative-free IOP-lowering eye drop containers: A comparison of two multi-dose bottles
Kai Kaarniranta and Auli Ropo
Case Report: Clinical Investigation
-
Preferences and ease of use of preservative-free IOP-lowering eye drop containers: A comparison of two multi-dose bottles
Kai Kaarniranta and Auli Ropo
Case Report: Clinical Investigation
-
Preferences and ease of use of preservative-free IOP-lowering eye drop containers: A comparison of two multi-dose bottles
Kai Kaarniranta and Auli Ropo
Case Report: Clinical Investigation
-
A twice-daily, fixed-dose combination of aclidinium bromide and formoterol fumarate for the treatment of COPD
Jutta Beier
Drug Evaluation: Clinical Investigation
-
A twice-daily, fixed-dose combination of aclidinium bromide and formoterol fumarate for the treatment of COPD
Jutta Beier
Drug Evaluation: Clinical Investigation
-
A twice-daily, fixed-dose combination of aclidinium bromide and formoterol fumarate for the treatment of COPD
Jutta Beier
Drug Evaluation: Clinical Investigation
-
A twice-daily, fixed-dose combination of aclidinium bromide and formoterol fumarate for the treatment of COPD
Jutta Beier
Drug Evaluation: Clinical Investigation
-
A twice-daily, fixed-dose combination of aclidinium bromide and formoterol fumarate for the treatment of COPD
Jutta Beier
Drug Evaluation: Clinical Investigation
-
A twice-daily, fixed-dose combination of aclidinium bromide and formoterol fumarate for the treatment of COPD
Jutta Beier
Drug Evaluation: Clinical Investigation
-
A twice-daily, fixed-dose combination of aclidinium bromide and formoterol fumarate for the treatment of COPD
Jutta Beier
Drug Evaluation: Clinical Investigation
-
A twice-daily, fixed-dose combination of aclidinium bromide and formoterol fumarate for the treatment of COPD
Jutta Beier
Drug Evaluation: Clinical Investigation
-
An update on clinical trials in Charcot-Marie-Tooth Disease
Davide Pareyson & Giuseppe Piscosquito
Commentary: Clinical Investigation
-
An update on clinical trials in Charcot-Marie-Tooth Disease
Davide Pareyson & Giuseppe Piscosquito
Commentary: Clinical Investigation
-
An update on clinical trials in Charcot-Marie-Tooth Disease
Davide Pareyson & Giuseppe Piscosquito
Commentary: Clinical Investigation
-
An update on clinical trials in Charcot-Marie-Tooth Disease
Davide Pareyson & Giuseppe Piscosquito
Commentary: Clinical Investigation
-
An update on clinical trials in Charcot-Marie-Tooth Disease
Davide Pareyson & Giuseppe Piscosquito
Commentary: Clinical Investigation
-
An update on clinical trials in Charcot-Marie-Tooth Disease
Davide Pareyson & Giuseppe Piscosquito
Commentary: Clinical Investigation
-
An update on clinical trials in Charcot-Marie-Tooth Disease
Davide Pareyson & Giuseppe Piscosquito
Commentary: Clinical Investigation
-
An update on clinical trials in Charcot-Marie-Tooth Disease
Davide Pareyson & Giuseppe Piscosquito
Commentary: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Zoledronic acid in conjunction with chemotherapy: bisphosphonate gives fresh hope for newly diagnosed multiple myeloma patients
News and Views: Clinical Investigation
-
Zoledronic acid in conjunction with chemotherapy: bisphosphonate gives fresh hope for newly diagnosed multiple myeloma patients
News and Views: Clinical Investigation
-
Zoledronic acid in conjunction with chemotherapy: bisphosphonate gives fresh hope for newly diagnosed multiple myeloma patients
News and Views: Clinical Investigation
-
Zoledronic acid in conjunction with chemotherapy: bisphosphonate gives fresh hope for newly diagnosed multiple myeloma patients
News and Views: Clinical Investigation
-
Zoledronic acid in conjunction with chemotherapy: bisphosphonate gives fresh hope for newly diagnosed multiple myeloma patients
News and Views: Clinical Investigation
-
Zoledronic acid in conjunction with chemotherapy: bisphosphonate gives fresh hope for newly diagnosed multiple myeloma patients
News and Views: Clinical Investigation
-
Zoledronic acid in conjunction with chemotherapy: bisphosphonate gives fresh hope for newly diagnosed multiple myeloma patients
News and Views: Clinical Investigation
-
Zoledronic acid in conjunction with chemotherapy: bisphosphonate gives fresh hope for newly diagnosed multiple myeloma patients
News and Views: Clinical Investigation